Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1985-01-11
1986-05-13
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514280, 514321, 514400, 514909, A61K 3144, A61K 3150, A61K 31445, A61K 31495
Patent
active
045887241
ABSTRACT:
A treatment for accelerating regional weight reduction in humans, wherein an active ingredient encouraging elimination of fatty deposits, preferably a beta adrenergic stimulator or an alpha-2 adrenergic inhibitor, is selectively delivered to a regional fat deposit prior to commencing or during a general weight control program, whereby body weight is preferentially reduced in the selected area. The beta adrenergic stimulator, preferably isoproterenol or forskolin, or the alpha-2 adrenergic inhibitor, preferably yohimbine, or combinations thereof may be delivered by any means accomplishing specific delivery to the selected area, including injection, implantation, and topical application to the skin as in an ointment or creme.
REFERENCES:
Chem. Abst. 92: 28565m (1980)-Sandoz A-G.
Chem. Abst. 96: 91641f (1982)-Navarro et al.
Chem. Abst. 101: 168203a (1984)-Callahan et al.
Chem. Abst. 101: 144000(b) (1984)-Dulloo et al.
Bray George A.
Greenway, III Frank L.
LandOfFree
Treatment for selective reduction of regional fat deposits does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment for selective reduction of regional fat deposits, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for selective reduction of regional fat deposits will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1770280